Cargando…

Drug-induced liver injury: Do we know everything?

Interest in drug-induced liver injury (DILI) has dramatically increased over the past decade, and it has become a hot topic for clinicians, academics, pharmaceutical companies and regulatory bodies. By investigating the current state of the art, the latest scientific findings, controversies, and gui...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alempijevic, Tamara, Zec, Simon, Milosavljevic, Tomica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387361/ https://www.ncbi.nlm.nih.gov/pubmed/28443154 http://dx.doi.org/10.4254/wjh.v9.i10.491

Ejemplares similares

Translation and validation of the Serbian primary biliary cholangitis-40 questionnaire
por: Zec, Simon, et al.
Publicado: (2017)

Statin Intolerance—We Know Everything, We Know Nothing
por: Banach, Maciej
Publicado: (2022)

Adherence to statin therapy: it seems we know everything, yet we do nothing
por: Banach, Maciej, et al.
Publicado: (2022)

Suicide and quarantine during the COVID-19 pandemic: Do we know everything?
por: Duarte, Fabián, et al.
Publicado: (2022)

Liver injury induced by COVID 19 treatment – what do we know?
por: Saha, Lekha, et al.
Publicado: (2022)

Dynamic Compression of the Ulnar Nerve Associated With the Anconeus Epitrochlearis Muscle: Do We Really Know Everything?
por: Sanjuan-Cervero, Rafael, et al.
Publicado: (2022)

Risk Factors for Osteoporosis among Patients with Inflammatory Bowel Disease—Do We Already Know Everything?
por: Lewandowski, Konrad, et al.
Publicado: (2023)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

Focal Lesions of the Liver and Radiomics: What Do We Know?
por: Anichini, Matilde, et al.
Publicado: (2023)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Cerebrospinal fluid circulation: What do we know and how do we know it?
por: Khasawneh, Ahmad H, et al.
Publicado: (2018)

Liver injury in COVID-19: What do we know now?
por: Yang, Hua-Yu, et al.
Publicado: (2020)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

Sodium and brain injury: do we know what we are doing?
por: Zygun, David A
Publicado: (2009)

Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

Health Statistics in Australia: What We Know and Do Not Know
por: Madden, Richard, et al.
Publicado: (2022)

Diagnostic Accuracy of Platelet Count and Platelet Indices in Noninvasive Assessment of Fibrosis in Nonalcoholic Fatty Liver Disease Patients
por: Milovanovic Alempijevic, Tamara, et al.
Publicado: (2017)

Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?
por: Gershman, Boris, et al.
Publicado: (2015)

Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Rai, Mahendra, et al.
Publicado: (2021)

Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
por: Pinheiro, Rúben G. R., et al.
Publicado: (2021)

Radiation-induced lung injury — what do we know in the era of modern radiotherapy?
por: Konkol, Marek, et al.
Publicado: (2022)

COVID-19 and the liver: What do we know so far?
por: Nasa, Prashant, et al.
Publicado: (2021)

Autoimmune liver disease - are there spectra that we do not know?
por: Fallatah, Hind I, et al.
Publicado: (2011)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

Equine Crofton Weed (Ageratina spp.) Pneumotoxicity: What Do We Know and What Do We Need to Know?
por: Shapter, Frances Marie, et al.
Publicado: (2023)

How to predict everything: the formula transforming what we know about life and the universe
por: Poundstone, William
Publicado: (2020)

Mechanisms of atrial fibrillation in athletes: what we know and what we do not know
por: Guasch, E., et al.
Publicado: (2018)

The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know
por: Goldstein, David S.
Publicado: (2021)

Chikungunya and diabetes, what do we know?
por: de Almeida Barreto, Francisca Kalline, et al.
Publicado: (2018)

Nutrition and Sarcopenia—What Do We Know?
por: Ganapathy, Aravinda, et al.
Publicado: (2020)

Roxadustat: Do we know all the answers?
por: Li, Qiu-Yu, et al.
Publicado: (2023)

What do we know about pseudodementia?
por: Mouta, Salomé, et al.
Publicado: (2023)

Do we understand everything about MP system response?
por: Zerlauth, M
Publicado: (2010)

How: why how we do anything means everything
por: Seidman, Dov
Publicado: (2007)

Liver transplantation in elderly patients: what do we know at the beginning of 2020?
por: Dolnikov, Shimon, et al.
Publicado: (2020)

Acute kidney injury in critically ill newborns: What do we know? What do we need to learn?
por: Askenazi, David J., et al.
Publicado: (2009)

Isolated Nocturnal Hypertension: What Do We Know and What Can We Do?
por: Tadic, Marijana, et al.
Publicado: (2020)

Drivers and Distribution of Henipavirus-Induced Syncytia: What Do We Know?
por: Gamble, Amandine, et al.
Publicado: (2021)

Plastic Interactions with Pollutants and Consequences to Aquatic Ecosystems: What We Know and What We Do Not Know
por: Cássio, Fernanda, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pu24eqmlpn25k1hpris29rp8nr